Overcoming drug resistance in osteosarcoma and pancreatic adenocarcinoma with radioimmunotherapy
Reference43 articles.
1. Malignant bone tumors;Gurney,1999
2. Cancer in adolescents 15 to 19 years old;Smith,1999
3. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons;Mirabello;Int J Cancer,2009
4. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate;Meyers;J Clin Oncol,2005
5. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups;Ferrari;J Clin Oncol,2005